United States Endoscopy Devices Market: Innovation, Demand & the Future of Minimally Invasive Care (2025–2033)

The United States healthcare sector has long been a global epicenter for medical innovation, patient access, and rapid adoption of cutting-edge technology—and few markets reflect that momentum better than endoscopy devices. Initially developed to give clinicians internal visibility into the human body without invasive surgery, endoscopes today are advancing into high-precision, AI-assisted, ultra-safe instruments that diagnose and treat conditions in real time.

According to Renub Research, the United States Endoscopy Devices Market was valued at US$ 12.23 billion in 2024 and is projected to reach US$ 20.76 billion by 2033, registering a CAGR of 6.06% (2025–2033). This impressive growth is fueled by five major pillars:

A surge in chronic diseases (GI disorders, cancer, arthritis, spinal tumors)

Expansion of minimally invasive procedures

Migration toward outpatient and ASC (Ambulatory Surgery Center) care

Accelerated adoption of AI and HD imaging technologies

A shift toward infection-safe single-use endoscopy devices

With hospitals striving to boost procedural accuracy, reduce patient infection risk, and process more cases in shorter recovery windows, the endoscopy market has transformed into one of the most dynamic segments in modern MedTech.

Why the U.S. is Leading the Endoscopy Revolution

America's healthcare infrastructure supports rapid deployment of high-end medical devices at a national scale. Several macro-trends are powering this industry:

Soaring chronic disease burden: According to the CDC, 58.5 million Americans suffer from arthritis, and the American Cancer Society estimates 24,810 new cases of malignant brain or spinal tumors in 2023 alone.

Aging population: Older adults experience higher gastrointestinal, neurological, and respiratory ailments—conditions heavily dependent on endoscopic diagnosis and treatment.

Healthcare decentralization: Procedures once confined to large hospitals are shifting to ASCs, outpatient clinics, and specialized endoscopy centers that prioritize speed, comfort, and cost-effectiveness.

Technological leaps: AI image interpretation, 4K imaging, 3D visualization, robotic assistance, and cloud-supported analysis are rapidly becoming standard features.

One example of institutional adoption includes UC Davis Health launching an advanced endoscopy suite in January 2023, expanding diagnostic capacity and improving real-time care.

Game-Changing Market Drivers

1. Rising Obesity & Growth in Bariatric Endoscopy

The U.S. has one of the highest obesity rates globally, amplifying demand for non-surgical weight-loss treatments. Procedures like:

Endoscopic sleeve gastroplasty

Intragastric balloon implantation

are gaining traction thanks to shorter recovery periods, fewer complications, and increasing insurance coverage. These options are creating robust demand for next-gen endoscopes optimized for bariatric care.

2. Boom in Single-Use (Disposable) Endoscopes

After years of concern over patient cross-infection, hospitals are aggressively prioritizing sterile, pre-packaged, non-reprocessable scopes. The benefits include:

Zero sterilization requirement

Lower contamination risk

High procedural efficiency

Better compliance with infection-control regulations

Tech giants are driving innovation too—Olympus and NTT Corporation unveiled a cloud-based endoscopic system in March 2024, leveraging ultra-low latency and AI for higher procedural accuracy.

3. AI Integration Is No Longer Optional

AI is transforming endoscopy from a visual examination to a data-driven diagnostic procedure. Real-time lesion detection, contrast enhancement, polyp characterization, and anomaly flagging are redefining patient outcomes.

A major milestone: FDA approval of ANX Robotica’s AI-powered CapsuleX system on January 3, 2024, designed to enhance small bowel imaging and improve diagnostic precision in GI care.

Market Challenges That Still Demand Attention

❗High Competition & Market Saturation

The landscape is dominated by global heavyweights like:

Medtronic

Olympus

Stryker

Boston Scientific

Johnson & Johnson

Smaller manufacturers often struggle to secure hospital contracts, compete on pricing, or scale production. Innovation is essential—but expensive regulatory requirements and R&D timelines create steep entry barriers.

❗Reprocessing Costs for Reusable Scopes

Reusable scopes must undergo meticulous sterilization and high-level disinfection—processes that are:

Labor-intensive

Costly

Dependent on highly trained technicians

Vulnerable to contamination risk if compliance lapses

These factors are pushing more facilities toward disposable solutions… despite their higher per-use cost.

Segment Intelligence: What’s Driving the Market?

🔹 By Product Type

Endoscopes themselves lead the market due to their versatility in diagnosing GI, pulmonary, urological, ENT, and neurological diseases. Continuous upgrades in imaging clarity, maneuverability, and precision make them indispensable.

🔹 By Application

Gastrointestinal endoscopy dominates the space, enabling early detection of:

Polyps

Inflammatory bowel disease

Ulcers

GI cancers

Internal bleeding

Millions of GI endoscopy procedures are performed annually, making it the most widely utilized category.

🔹 By Hygiene

Single-use devices are the fastest-growing segment, thanks to their role in:

Infection prevention

Reduced turnaround times

Improved safety in high-volume clinical environments

🔹 By End-User

Hospitals hold the largest share due to their high patient volumes, multi-specialty departments, and complex surgical needs. However, Ambulatory Surgery Centers (ASCs) are the fastest-growing installation segment due to cost efficiency and convenience.

State-Level Market Insights

🌐 1. California

Leader in medical innovation & adoption

Strong outpatient ecosystem

Home to med-tech R&D and regulatory activity

High utilization of GI, pulmonary, and robot-assisted endoscopy

🌐 2. Texas

Rapidly expanding healthcare infrastructure

Rising demand for chronic disease management

Growth of endoscopy in oncology, pulmonology, and GI care

🌐 3. New York

Dense hospital network and academic medical hub

High patient inflow for specialty treatment

Early AI and robotic integration in medical procedures

🌐 4. Florida

Large aging patient demographic

Significant demand for cancer, GI, and respiratory diagnostics

Rising adoption of 4K and HD imaging platforms

These states, alongside Illinois, Pennsylvania, Georgia, New Jersey, and others, contribute the largest treatment volume nationwide.

Market Segmentation Snapshot

✅ Product Types

Endoscopes

Visualization & Documentation Systems

Mechanical Endoscopic Equipment

Accessories

Other Endoscopy Equipment

✅ Applications

Bronchoscopy • Arthroscopy • Laparoscopy • Urology • Neuroendoscopy • GI Endoscopy • Gynecology • ENT • Others

✅ Hygiene Categories

Single-Use • Reprocessing • Sterilization

✅ End Users

Hospitals • Ambulatory Surgery Centers • Others

✅ State Coverage (29 States + Rest of US)

Including California, Texas, New York, Florida, Illinois, Washington, North Carolina, Arizona, Tennessee, and more.

Major Industry Players

The U.S. endoscopy ecosystem is driven by global and domestic leaders, each evaluated across:

✔ Business Overview

✔ Recent Developments

✔ Revenue Performance

Key companies include:

Johnson & Johnson

Stryker

Boston Scientific

CONMED

Medtronic Plc

Fujifilm Holdings

Smith & Nephew

Final Thoughts: What’s Next for U.S. Endoscopy?

The U.S. endoscopy devices market is undergoing a structural transformation. With:

AI-dynamic diagnosis

Sterile single-use device adoption

Remote/cloud-guided procedures

Rising chronic disease incidence

A shift toward outpatient care

Continuous R&D investments

…the trajectory toward US$ 20.76 billion by 2033 appears not just realistic—but inevitable.

Healthcare providers are no longer asking if endoscopy should evolve, but how fast it can improve. As hospitals, tech companies, and regulators work in sync, the endoscopy operating room is becoming smarter, safer, and significantly more patient-centered.